Invizyne Technologies Inc. (IZTC)
Invizyne Technologies will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.00
Shares Offered
4,300,000
Deal Size
$17.20M
Company Description
Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals.
Our objective with SimplePath™, our biomanufacturing platform, is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
We believe that SimplePath™ not only can maximize the value of these resources but also will contribute to the development of novel chemical compounds that should open new markets and business opportunities.
Invizyne Technologies Inc.
| Country | United States |
| Founded | 2019 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 29 |
| CEO | Michael Heltzen |
Contact Details
Address: 750 Royal Oaks Drive, Suite 106 Monrovia, CA 91016 United States | |
| Phone | (626) 415-1488 |
| Website | invizyne.com |
Stock Details
| Ticker Symbol | IZTC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0002010788 |
| Employer ID | 83-4550057 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael Heltzen | Chief Executive Officer |
| Fouad Nawaz | Vice President, Finance |
| Tyler Korman | Vice President, Research |
| Paul Opgenorth | Vice President, Development |
| Mo Hayat | Chairman of the Board, President |
| Christopher A. Marlett | Director |
| Anthony DiGiandomenico | Director |
| James U. Bowie | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 30, 2024 | FWP | Free Writing Prospectus |
| May 22, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 17, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 14, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 9, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |